메뉴 건너뛰기
European Journal of Cancer
Volumn 32, Issue 4, 1996, Pages 737-738
Rapid Tumour Lysis Syndrome in a Metastatic Colorectal Cancer Increased by Treatment with Irinotecan (CPT-11)
Author keywords

[No Author keywords available]
Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;
EID: 0030009770     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00654-0     Document Type: Letter
Times cited : (20)
References (4)
  • 1
    • 0028037089 scopus 로고
    • Tumor lysis syndrome in nonhematologic malignancies: Report of a case and review of the literature
    • Drakos P, Bar-Ziv J, Catane R. Tumor lysis syndrome in nonhematologic malignancies: report of a case and review of the literature. Am J Clin Oncol 1994, 17, 502-505.
    • (1994) Am J Clin Oncol , vol.17 , pp. 502-505
    • Drakos, P.1    Bar-Ziv, J.2    Catane, R.3
  • 2
    • 0024311457 scopus 로고
    • Tumor lysis syndrome in nonhematopoietic neoplasms
    • Barton J. Tumor lysis syndrome in nonhematopoietic neoplasms. Cancer 1989, 64, 738-740.
    • (1989) Cancer , vol.64 , pp. 738-740
    • Barton, J.1
  • 3
    • 0029084773 scopus 로고
    • CPT-11 (Irinotecan) in the treatment of colorectal cancer
    • Armand JP, Ducreux M, Mahjoubi M, et al. CPT-11 (Irinotecan) in the treatment of colorectal cancer. Eur J Cancer 1995, 31A, 1283-1287.
    • (1995) Eur J Cancer , vol.31 A , pp. 1283-1287
    • Armand, J.P.1    Ducreux, M.2    Mahjoubi, M.3
  • 4
    • 0028853410 scopus 로고
    • Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials
    • Chabot G, Abigerges D, Catimel G, et al. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials. Ann Oncol 1995, 6, 141-151.
    • (1995) Ann Oncol , vol.6 , pp. 141-151
    • Chabot, G.1    Abigerges, D.2    Catimel, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.